(Q41365006)

29 September 2017

title

Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway (English)

1 reference

29 September 2017

0 references

1 reference

R A Gjerset

1

1 reference

29 September 2017

H Fakhrai

2

1 reference

29 September 2017

D L Shawler

3

1 reference

29 September 2017

S Turla

4

1 reference

29 September 2017

O Dorigo

5

1 reference

29 September 2017

A Grover-Bardwick

6

1 reference

29 September 2017

D Mercola

7

1 reference

29 September 2017

S F Wen

8

1 reference

29 September 2017

H Collins

9

1 reference

29 September 2017

H Lin

10

1 reference

29 September 2017

publication date

1 March 1995

1 reference

In Vitro Cellular & Developmental Biology - Animal

29 September 2017

published in

1 reference

29 September 2017

volume

31

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

207-214

1 reference

describes a project that uses

29 September 2017

GT9

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/bf02639435

0 references

cites work

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02639435

Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

21 January 2018

1 reference

12 December 2020

Interleukin-2 gene therapy in a patient with glioblastoma

1 reference

12 December 2020

Retinoblastoma protein monoclonal antibodies with novel characteristics

1 reference

12 December 2020

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

1 reference

12 December 2020

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression

1 reference

12 December 2020

Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11

1 reference

12 December 2020

Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.

1 reference

12 December 2020

The transcriptional factor Egr-1 is synthesized by baculovirus-infected insect cells in an active, DNA-binding form

1 reference

12 December 2020

Gene amplification in cultured cells

1 reference

12 December 2020

Mutations in the p53 gene occur in diverse human tumour types

1 reference

12 December 2020

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

12 December 2020

Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines

1 reference

12 December 2020

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele

1 reference

12 December 2020

Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells

1 reference

12 December 2020

Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses

1 reference

12 December 2020

p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency

1 reference

12 December 2020

The future of therapy for glioblastoma

1 reference

12 December 2020

Loss of heterozygosity for 10q loci in human gliomas

1 reference

12 December 2020

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

12 December 2020

Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas

1 reference

12 December 2020

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

1 reference

12 December 2020

Analysis of the p53 gene and its expression in human glioblastoma cells

1 reference

12 December 2020

Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells

1 reference

12 December 2020

Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity

1 reference

12 December 2020

Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study.

1 reference

12 December 2020

Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

1 reference

12 December 2020

Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells

1 reference

12 December 2020

Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

The putative melanoma tumor-suppressor gene on human chromosome 6q

1 reference

12 December 2020

Rapid, complete and reversible transformation by v-sis precedes irreversible transformation

1 reference

12 December 2020

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

12 December 2020

p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma

1 reference

12 December 2020

p53 mutation hotspot in radon-associated lung cancer

1 reference

12 December 2020

Cytogenetics of human brain tumors

1 reference

12 December 2020

Clonal genomic alterations in glioma malignancy stages.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02639435

1 reference

Dimensions Publication ID

29 September 2017

1029980636

0 references

1 reference